Since a specific inhibitor was available for GCLC, we focused on this protein and studied the effect of GCLC inhibition with BSO alone or in combination with commonly used chemotherapeutics on survival of BL cells. The gene discussed is GCLC; the disease is Burkitt lymphoma.